I agree that this site is using cookies. You can find further informations here.
X
Catherine Thieblemont
823  results:
Online X
Search for persons X
?
1

Early progression of disease predicts shorter survival in M..:

Annarita Conconi ; Catherine Thieblemont ; Luciano Cascione...
Haematologica.  105 (2020)  11 - p. 2592-2597 , 2020
Link: https://doi.org/10.3324/..
 
?
2

Clinical activity of abemaciclib in patients with relapsed ..:

Franck Morschhauser ; Kamal Bouabdallah ; Stephan Stilgenbauer...
Haematologica.  106 (2020)  3 - p. 859-862 , 2020
Link: https://doi.org/10.3324/..
 
?
3

Epcoritamab monotherapy in patients with relapsed or refrac..:

Linton, Kim M ; Vitolo, Umberto ; Jurczak, Wojciech...
The Lancet Haematology.  11 (2024)  8 - p. e593-e605 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Author Correction: Axicabtagene ciloleucel as second-line t..:

Houot, Roch ; Bachy, Emmanuel ; Cartron, Guillaume...
Nature Medicine.  30 (2024)  7 - p. 2089-2089 , 2024
Link: https://doi.org/10.1038/..
 
?
5

Deep and Durable Responses with Epcoritamab SC Monotherapy ..:

Linton, Kim M ; Jurczak, Wojciech ; Lugtenburg, Pieternella J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S33-S34 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Axicabtagene ciloleucel vs standard of care in second-line ..:

Locke, Frederick L. ; Oluwole, Olalekan O. ; Kuruvilla, John...
Blood.  143 (2024)  24 - p. 2464-2473 , 2024
Link: https://doi.org/10.1182/..
 
?
7

Challenges for quality and utilization of real-world data f..:

Ghesquières, Hervé ; Cherblanc, Fanny ; Belot, Aurélien...
Blood Advances.  8 (2024)  2 - p. 296-308 , 2024
Link: https://doi.org/10.1182/..
 
?
8

Phase IB Study of Oral Selinexor in Combination with Rituxi..:

Maerevoet, Marie ; Casasnovas, Olivier ; Cartron, Guillaume...
Cancers.  16 (2024)  15 - p. 2672 , 2024
Link: https://doi.org/10.3390/..
 
?
9

Acute kidney injury after CAR-T cell therapy: exploring cli..:

Vincendeau, Maud ; Joseph, Adrien ; Thieblemont, Catherine...
Clinical Kidney Journal.  17 (2024)  6 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
10

Long-Term Durable Responses in Patients with Relapsed/Refra..:

Awasthi, Rakesh ; Waldron, Edward ; Grupp, Stephan A....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S198-S199 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Oral azacitidine compared with standard therapy in patients..:

Dupuis, Jehan ; Bachy, Emmanuel ; Morschhauser, Franck...
The Lancet Haematology.  11 (2024)  6 - p. e406-e414 , 2024
Link: https://doi.org/10.1016/..
 
?
12

A phase 2 study of the PI3Kδ inhibitor parsaclisib in relap..:

Phillips, Tycel J. ; Avigdor, Abraham ; Gurion, Ronit...
Blood Advances.  8 (2024)  4 - p. 867-877 , 2024
Link: https://doi.org/10.1182/..
 
?
13

Hematopoietic stem cell transplantation for DLBCL: a report..:

Berning, Philipp ; Fekom, Mathilde ; Ngoya, Maud...
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
14

An Updated Comparison of Overall Survival with Brexucabtage..:

Hess, Georg ; Dreyling, Martin ; Oberic, Lucie...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S359-S360 , 2024
Link: https://doi.org/10.1016/..
 
?
15

Long-term outcomes of patients with large B-cell lymphoma t..:

Oluwole, Olalekan O. ; Forcade, Edouard ; Muñoz, Javier...
Bone Marrow Transplantation.  59 (2024)  3 - p. 366-372 , 2024
Link: https://doi.org/10.1038/..
 
1-15